$1.40
11.67% yesterday
Nasdaq, Apr 04, 10:10 pm CET
ISIN
US14161W1053
Symbol
CDLX

Cardlytics, Inc. Stock price

$1.40
-1.04 42.51% 1M
-1.89 57.45% 6M
-2.31 62.26% YTD
-11.67 89.29% 1Y
-56.46 97.58% 3Y
-36.11 96.27% 5Y
-11.97 89.53% 10Y
Nasdaq, Closing price Fri, Apr 04 2025
-0.19 11.67%
ISIN
US14161W1053
Symbol
CDLX

Key metrics

Market capitalization $72.92m
Enterprise Value $228.98m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.82
P/S ratio (TTM) P/S ratio 0.26
P/B ratio (TTM) P/B ratio 1.03
Revenue growth (TTM) Revenue growth -10.00%
Revenue (TTM) Revenue $278.30m
EBIT (operating result TTM) EBIT $-63.53m
Free Cash Flow (TTM) Free Cash Flow $-10.39m
Cash position $65.59m
EPS (TTM) EPS $-3.86
P/E forward negative
P/S forward 0.27
EV/Sales forward 0.84
Short interest 18.81%
Show more

Is Cardlytics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Cardlytics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Cardlytics, Inc. forecast:

5x Hold
83%
1x Sell
17%

Analyst Opinions

6 Analysts have issued a Cardlytics, Inc. forecast:

Hold
83%
Sell
17%

Financial data from Cardlytics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
278 278
10% 10%
100%
- Direct Costs 153 153
13% 13%
55%
125 125
6% 6%
45%
- Selling and Administrative Expenses 111 111
4% 4%
40%
- Research and Development Expense 50 50
3% 3%
18%
-36 -36
2% 2%
-13%
- Depreciation and Amortization 28 28
2% 2%
10%
EBIT (Operating Income) EBIT -64 -64
0% 0%
-23%
Net Profit -189 -189
41% 41%
-68%

In millions USD.

Don't miss a Thing! We will send you all news about Cardlytics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cardlytics, Inc. Stock News

Neutral
GlobeNewsWire
21 days ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cardlytics To Contact Him Directly To Discuss Their Options
Neutral
PRNewsWire
23 days ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson  Encourages Investors Who Suffered Losses Exceeding $50,000 In Cardlytics To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Cardlytics  between March 14, 2024 and August 7, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247...
Neutral
Seeking Alpha
23 days ago
Cardlytics, Inc. (NASDAQ:CDLX ) Q4 2024 Results Conference Call March 12, 2025 5:00 PM ET Company Participants Nick Lynton - Chief Legal & Privacy Officer Amit Gupta - Chief Executive Officer Alexis DeSieno - Chief Financial Officer Conference Call Participants Luke Horton - Northland Securities Kyle Peterson - Needham Cal Bartyzal - Craig-Hallum Robert Coolbrith - Evercore ISI Operator Good af...
More Cardlytics, Inc. News

Company Profile

Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Head office United States
CEO Amit Gupta
Employees 454
Founded 2008
Website www.cardlytics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today